Screening for depression in children and adolescents: U.S. Preventive services task force recommendation statement

Annals of Internal Medicine

Volumn 164, Issue 5, 2016, Pages 360-366

  Siu, Albert L ^a,b   Bibbins Domingo, Kirsten ^c   Grossman, David C ^d   Baumann, Linda Ciofu ^e   Davidson, Karina W ^f   Ebell, Mark ^g   García, Francisco A R ^h   Gillman, Matthew ⁱ   Herzstein, Jessica ^j   Kemper, Alex R ^k   Krist, Alex H ^l,m   Kurth, Ann E ⁿ   Owens, Douglas K ^o,p   Phillips, William R ^q   Phipps, Maureen G ^r   Pignone, Michael P ^s  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d GROUP HEALTH RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

^f Och Spine at New York Presbyterian Hospitals   (United States)

^g UNIVERSITY OF GEORGIA   (United States)

^h Pima County Health Department   (United States)

ⁱ HARVARD MEDICAL SCHOOL   (United States)

^j Duke University ^*  (United States)

^k DUKE UNIVERSITY   (United States)

^l Fairfax Family Practice Centers   (United States)

^m VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

ⁿ NEW YORK UNIVERSITY   (United States)

^o VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^p STANFORD UNIVERSITY   (United States)

^q UNIVERSITY OF WASHINGTON   (United States)

^r BROWN UNIVERSITY   (United States)

^s UNIVERSITY OF NORTH CAROLINA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT; ADOLESCENT DISEASE; CHILD; CHILDHOOD DISEASE; DIAGNOSTIC ACCURACY; FEASIBILITY STUDY; FOLLOW UP; HUMAN; INTERVENTION STUDY; MAJOR DEPRESSION; PREVENTIVE HEALTH SERVICE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SCREENING TEST; SYSTEMATIC REVIEW (TOPIC); UNITED STATES; ADVERSE EFFECTS; COST OF ILLNESS; DEPRESSIVE DISORDER, MAJOR; MASS SCREENING; PRACTICE GUIDELINE; PRIMARY HEALTH CARE; PSYCHOLOGY;

ADOLESCENT; CHILD; COST OF ILLNESS; DEPRESSIVE DISORDER, MAJOR; HUMANS; MASS SCREENING; PRIMARY HEALTH CARE; UNITED STATES;

EID: 84959308863     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M15-2957     Document Type: Review

References (20)

1. U.S. Food and Drug Administration. Antidepressant Use in Children, Adolescents, and Adults: Revisions to Product Labeling. Silver Spring, MD: U.S. Food and Drug Administration; 2007. Accessed at www.fda.gov/downloads/Drugs/DrugSafety/InformationbyDrug Class/UCM173233.pdf on 21 August 2015.
2. Kramer T, Iliffe S, Gledhill J, Garralda ME. Recognising and responding to adolescent depression in general practice: developing and implementing the Therapeutic Identification of Depression in Young people (TIDY) programme. Clin Child Psychol Psychiatry. 2012;17:482-94. [PMID: 22523137] doi:10.1177/1359104512442639
3. Forman-Hoffman V, McClure E, McKeeman J, Wood CT, Cook Middleton J, Skinner AC, et al. Screening for Major Depressive Disorder in Children and Adolescents: A Systematic Review for the U.S. Preventive Services Task Force. Evidence synthesis no. 116. AHRQ publication no. 13-05192-EF-1. Rockville, MD: Agency for Healthcare Research and Quality; 2016.
4. Forman-Hoffman V, McClure E, McKeeman J, Wood CT, Cook Middleton J, Skinner AC, et al. Screening for major depressive disorder in children and adolescents: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2016;164:342-49. [PMID: 26857836] doi:10.7326/M15-2259
5. Johnson JG, Harris ES, Spitzer RL, Williams JB. The Patient Health Questionnaire for Adolescents: validation of an instrument for the assessment of mental disorders among adolescent primary care patients. J Adolesc Health. 2002;30:196-204. [PMID: 11869927]
6. Canals J, Bladé J, Carbajo G, Domènech-Llabería E. The Beck Depression Inventory: psychometric characteristics and usefulness in nonclinical adolescents. Eur J Psychol Assess. 2001;17:63-8.
7. Roberts RE, Lewinsohn PM, Seeley JR. Screening for adolescent depression: a comparison of depression scales. J Am Acad Child Adolesc Psychiatry. 1991;30:58-66. [PMID: 2005065]
8. Garrison CZ, Addy CL, Jackson KL, McKeown RE, Waller JL. The CES-D as a screen for depression and other psychiatric disorders in adolescents. J Am Acad Child Adolesc Psychiatry. 1991;30:636-41. [PMID: 1890099]
9. Patton GC, Coffey C, Posterino M, Carlin JB, Wolfe R, Bowes G. A computerised screening instrument for adolescent depression: population-based validation and application to a two-phase casecontrol study. Soc Psychiatry Psychiatr Epidemiol. 1999;34:166-72. [PMID: 10327843]
10. March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, et al; Treatment for Adolescents With Depression Study (TADS) Team. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA. 2004;292: 807-20. [PMID: 15315995]
11. Kennard B, Silva S, Vitiello B, Curry J, Kratochvil C, Simons A, et al; TADS Team. Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry. 2006;45:1404-11. [PMID: 17135985]
12. Vitiello B, Rohde P, Silva S, Wells K, Casat C, Waslick B, et al; TADS Team. Functioning and quality of life in the Treatment for Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry. 2006;45:1419-26. [PMID: 17135987]
13. Wagner KD, Robb AS, Findling RL, Jin J, Gutierrez MM, Heydorn WE. A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents. Am J Psychiatry. 2004;161:1079-83. [PMID: 15169696]
14. Emslie GJ, Ventura D, Korotzer A, Tourkodimitris S. Escitalopram in the treatment of adolescent depression: a randomized placebocontrolled multisite trial. J Am Acad Child Adolesc Psychiatry. 2009; 48:721-9. [PMID: 19465881] doi:10.1097/CHI.0b013e3181a2b304
15. Wagner KD, Jonas J, Findling RL, Ventura D, Saikali K. A doubleblind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression. J Am Acad Child Adolesc Psychiatry. 2006;45:280-8. [PMID: 16540812]
16. Clarke GN, Rohde P, Lewinsohn PM, Hops H, Seeley JR. Cognitive-behavioral treatment of adolescent depression: efficacy of acute group treatment and booster sessions. J Am Acad Child Adolesc Psychiatry. 1999;38:272-9. [PMID: 10087688]
17. Richardson LP, Ludman E, McCauley E, Lindenbaum J, Larison C, Zhou C, et al. Collaborative care for adolescents with depression in primary care: a randomized clinical trial. JAMA. 2014;312:809-16. [PMID: 25157724] doi:10.1001/jama.2014.9259
18. Hagan JF Jr, Shaw JS, Duncan PM, eds. Bright Futures: Guidelines for Health Supervision of Infants, Children, and Adolescents. 3rd ed. Elk Grove Village, IL: American Academy of Pediatrics; 2008.
19. Health Resources and Services Administration. EPSDT Overview. Rockville, MD: Health Resources and Services Administration; 2015. Accessed at www.mchb.hrsa.gov/epsdt/overview.html on 21 August 2015.
20. MacMillan HL, Patterson CJ, Wathen CN. Screening for Depression in Primary Care: Updated Recommendations From the Canadian Task Force on Preventive Health Care. London, Ontario, Canada: Canadian Task Force on Preventive Health Care; 2004.